Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MedComm

Showing results (751-760 of 1,537) with videos related to

Pageof 154
Sort By:
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
Medcomm|November 17, 2025
Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical ManagementsYunkui Zhang, Meixi Chen, Xumeng Fang, et al.
Medcomm|November 17, 2025
Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort StudyYufang Ding, Mucong Li, Wei Bai, et al.
Medcomm|November 3, 2025
Antibiotic Resistance: A Genetic and Physiological PerspectiveRania G Elbaiomy, Ahmed H El-Sappah, Rong Guo, et al.
Medcomm|November 3, 2025
Synthesized Depside Molecules Suppress the Progression of Colorectal Cancer by Binding VDAC1/PHB/MMP9 Being at the Crossroads of Stemness, Motility, Apoptosis, and MetabolismMücahit Varlı, Young Hyun Yu, Jieun Yu, et al.
Medcomm|November 3, 2025
Implant Renal Injury-Responsive Cells to Supplement Erythropoietin and Protect Kidney InjuryHao Nie, Chen Liang, Yingxin He, et al.
Medcomm|October 8, 2025
Metabolite to Modifier: Lactate and Lactylation in the Evolution of TumorsLong Zhao, Haoyue Cui, Yutong Li, et al.
Medcomm|October 6, 2025
Hypertrophic Scarring and Keloids: Epidemiology, Molecular Pathogenesis, and Therapeutic InterventionsXiaowan Fang, Yuxiang Wang, Hao Chen, et al.
Medcomm|October 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)Yunxiang Zhou, Zhiyun Zhang, Huihui Chen, et al.
Medcomm|October 13, 2025
UFMylation System: Biological Functions, Molecular Mechanisms, Diseases, and Drug DiscoveryHuiyan Li, Fei Meng, Junjie Liang, et al.
Pageof 154

Showing results (751-760 of 1,537) with videos related to

Sort By:
Pageof 154
Medcomm|November 7, 2025
Neurofilament Light Chains in Serum Predict Post-Transjugular Intrahepatic Portosystemic Shunt Hepatic EncephalopathyChristian Labenz, Eva Maria Schleicher, Myriam Meineck, et al.
Medcomm|November 17, 2025
Progression and Metastasis of Lung Cancer: Clinical Features, Molecular Mechanisms, and Clinical ManagementsYunkui Zhang, Meixi Chen, Xumeng Fang, et al.
Medcomm|November 17, 2025
Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort StudyYufang Ding, Mucong Li, Wei Bai, et al.
Medcomm|November 3, 2025
Antibiotic Resistance: A Genetic and Physiological PerspectiveRania G Elbaiomy, Ahmed H El-Sappah, Rong Guo, et al.
Medcomm|November 3, 2025
Synthesized Depside Molecules Suppress the Progression of Colorectal Cancer by Binding VDAC1/PHB/MMP9 Being at the Crossroads of Stemness, Motility, Apoptosis, and MetabolismMücahit Varlı, Young Hyun Yu, Jieun Yu, et al.
Medcomm|November 3, 2025
Implant Renal Injury-Responsive Cells to Supplement Erythropoietin and Protect Kidney InjuryHao Nie, Chen Liang, Yingxin He, et al.
Medcomm|October 8, 2025
Metabolite to Modifier: Lactate and Lactylation in the Evolution of TumorsLong Zhao, Haoyue Cui, Yutong Li, et al.
Medcomm|October 6, 2025
Hypertrophic Scarring and Keloids: Epidemiology, Molecular Pathogenesis, and Therapeutic InterventionsXiaowan Fang, Yuxiang Wang, Hao Chen, et al.
Medcomm|October 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)Yunxiang Zhou, Zhiyun Zhang, Huihui Chen, et al.
Medcomm|October 13, 2025
UFMylation System: Biological Functions, Molecular Mechanisms, Diseases, and Drug DiscoveryHuiyan Li, Fei Meng, Junjie Liang, et al.
Pageof 154